# LAV

Source: https://onco.cc/companies/lav/  
OnCo record `lav` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A life-science venture capital firm with offices in Shanghai, Hong Kong and Palo Alto. It began in 2008 as a venture arm of the drug company Eli Lilly and became independent in 2011.

## Summary

LAV describes itself as a biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong and Palo Alto, investing in biopharmaceuticals, human therapeutics, medical devices and diagnostics (LAV website). It states that it originated in 2008 as a corporate venture subsidiary of Eli Lilly and spun off in 2011 to become an independent investment management company (LAV, About us).

## Fields

- Kind: Company
- Last checked: 2026-11-05
- Also known as: Lilly Asia Ventures; LAV Fund
- Tags: vc; corporate-venture
- HQ: Shanghai
- Type: investor
- Website: https://www.lavfund.com

## Notes

- The firm's pages use the name LAV; "Lilly Asia Ventures" appears in the site's own metadata and is the name under which the MD Anderson faculty profile of Cassian Yee lists a 2019 to 2021 consultancy.

## Sources

- LAV website: https://www.lavfund.com/
- LAV, About us: https://www.lavfund.com/about-us

## Connected records

- people: [Cassian Yee](https://onco.cc/people/cassian-yee/)

---
JSON: https://onco.cc/api/v1/entities/lav.json